Jentzer Jacob C, Berg David D, Chonde Meshe D, Dahiya Garima, Elliott Andrea, Rampersad Penelope, Sinha Shashank S, Truesdell Alexander G, Yohannes Seife, Vallabhajosyula Saraschandra
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
JACC Adv. 2024 Dec 5;4(1):101432. doi: 10.1016/j.jacadv.2024.101432. eCollection 2025 Jan.
This state-of-the-art review describes the potential etiologies, pathophysiology, and management of mixed shock in the context of a proposed novel classification system. Cardiogenic-vasodilatory shock occurs when cardiogenic shock is complicated by inappropriate vasodilation, impairing compensatory mechanisms, and contributing to worsening shock. Vasodilatory-cardiogenic shock occurs when vasodilatory shock is complicated by myocardial dysfunction, resulting in low cardiac output. Primary mixed shock occurs when a systemic insult triggers both myocardial dysfunction and vasoplegia. Regardless of the etiology of mixed shock, the hemodynamic profile can be similar, and outcomes tend to be poor. Identification and treatment of both the initial and complicating disease processes is essential along with invasive hemodynamic monitoring given the evolving nature of mixed shock states. Hemodynamic support typically involves a combination of inotropes and vasopressors, with few data available to guide the use of mechanical circulatory support. Consensus definitions and novel treatment strategies are needed for this dangerous condition.
这篇前沿综述在一个新提出的分类系统背景下,描述了混合性休克的潜在病因、病理生理学及管理方法。当心源性休克并发不适当的血管扩张,损害代偿机制并导致休克恶化时,就会发生心源性-血管扩张性休克。当血管扩张性休克并发心肌功能障碍,导致心输出量降低时,就会发生血管扩张性-心源性休克。当全身性损伤引发心肌功能障碍和血管麻痹时,就会发生原发性混合性休克。无论混合性休克的病因如何,其血流动力学特征可能相似,且预后往往较差。鉴于混合性休克状态不断变化的性质,识别和治疗初始及并发疾病过程以及进行有创血流动力学监测至关重要。血流动力学支持通常需要联合使用正性肌力药物和血管升压药,而关于使用机械循环支持的数据很少。对于这种危险情况,需要达成共识定义和新的治疗策略。